Sionna Therapeutics, Inc.'s market cap is currently $1.55B. The company's EPS TTM is $-0.46; its P/E ratio is -21.52; Sionna Therapeutics, Inc. is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Currency in USD
Sionna Therapeutics, Inc. Earnings and Revenue History
